UTILIZATION OF THE WHO MODEL LIST OF ESSENTIAL MEDICINES (EML) FOR ANTI-NEOPLASTIC DRUGS IN LOW AND MIDDLE INCOME COUNTRIES (LMICS)

被引：0
|
作者：
Barr, R. [1 ]
Robertson, J. [2 ]
机构：
[1] McMaster Univ, Pediat, Hamilton, ON, Canada
[2] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-023
引用
收藏
页码：S216 / S216
页数：1
相关论文
共 50 条
  • [1] Refocusing the World Health Organization ' s Model List of Essential Medicines on the needs of low and middle income countries
    Wirtz, Veronika J.
    Gray, Andrew L.
    Sharma, Sangeeta
    Sun, Jing
    Hogerzeil, Hans, V
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2024, 385 : e077776
  • [2] Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries
    Barbui, Corrado
    Papola, Davide
    Todesco, Beatrice
    Gastaldon, Chiara
    Ostuzzi, Giovanni
    [J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2024, 33
  • [3] Essential medicines for breast cancer in low and middle income countries
    Y. T. Bazargani
    A. de Boer
    J. H. M. Schellens
    H. G. M. Leufkens
    Aukje K. Mantel-Teeuwisse
    [J]. BMC Cancer, 15
  • [4] Essential medicines for breast cancer in low and middle income countries
    Bazargani, Y. T.
    de Boer, A.
    Schellens, J. H. M.
    Leufkens, H. G. M.
    Mantel-Teeuwisse, Aukje K.
    [J]. BMC CANCER, 2015, 15
  • [5] Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
    Zaheer-Ud-Din Babar
    [J]. Journal of Pharmaceutical Policy and Practice, 15
  • [6] Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
    Babar, Zaheer-Ud-Din
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [7] Essential medicines for COPD and asthma in low and middle-income countries
    Bazargani, Yaser T.
    de Boer, Anthonious
    Leufkens, Hubert G. M.
    Mantel-Teeuwisse, Aukje K.
    [J]. THORAX, 2014, 69 (12) : 1149 - 1151
  • [8] RESULTS OF PARENT SUPPORT GROUP AND HEALTH PROFESSIONAL SURVEYS ON KNOWLEDGE ABOUT AND ACCESS TO ESSENTIAL MEDICINES IN LOW/MIDDLE INCOME COUNTRIES (LMICS)
    Grynszpancholc, E.
    Wernikowski, J.
    Barr, R.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S347 - S347
  • [9] Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
    Bazargani, Yaser T.
    de Boer, Anthonius
    Leufkens, Hubert G. M.
    Mantel-Teeuwisse, Aukje K.
    [J]. PLOS ONE, 2014, 9 (09):
  • [10] Economic Costs of Adverse Reactions to Drugs (ADRs) in Low and Middle-income Countries (LMICs)
    Deoras, G.
    Iessa, N.
    Mantel-Teeuwisse, A. K.
    Pal, S.
    [J]. DRUG SAFETY, 2016, 39 (10) : 1016 - 1016
12345